EXCELINDUS

Excel Industries Limited

Specialty and commodity chemicals manufacturer

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

excelind.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹931.60
Market cap
1,171 Cr
Stock P/E
16.4
P/B
0.69
Dividend yield
1.5%
ROE (FY26)
4.4%
ROCE (FY26)
5.9%
Operating margin (FY26)
6.7%
Debt / equity (FY26)
0.0001
OCF / EBITDA (FY26)
48.2%
OCF / EBITDA (3Y)
74.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Excel Industries (Excel) is a chemicals maker whose core strength is phosphorus chemistry, selling agrochemical intermediates, phosphonates (used in water treatment, soaps and detergents, industrial and institutional cleaners and textile auxiliaries), biocides and other specialty chemicals, and also manufacturing under contract for other companies.

Company snapshot

41stBy market cap

Ranked among 68 companies in Specialty Chemicals.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 99.1% of revenue

SegmentRevenue shareRevenuePBTAssets
Chemicals
99.1%
195 Cr21 Cr751 Cr
Environment and Biotech
0.9%
2 Cr-2 Cr17 Cr

What we see

Positives
  • ✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales198 Cr180 Cr234 Cr265 Cr269 Cr196 Cr248 Cr310 Cr270 Cr234 Cr281 Cr294 Cr
Operating expenses (approx.)195 Cr179 Cr221 Cr226 Cr220 Cr184 Cr228 Cr267 Cr240 Cr218 Cr259 Cr251 Cr
EBITDA3 Cr2 Cr12 Cr39 Cr49 Cr12 Cr20 Cr42 Cr30 Cr16 Cr22 Cr42 Cr
OPM %1.3%0.9%5.2%14.7%18.2%6.1%7.9%13.6%11.1%6.7%7.8%14.4%
Other income7 Cr11 Cr5 Cr11 Cr8 Cr5 Cr6 Cr12 Cr7 Cr5 Cr3 Cr7 Cr
Interest0.26 Cr0.74 Cr0.29 Cr0.61 Cr1 Cr0.28 Cr0.26 Cr1 Cr0.75 Cr0.45 Cr0.25 Cr0.59 Cr
Depreciation8 Cr8 Cr8 Cr8 Cr9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr10 Cr10 Cr
Profit before tax2 Cr4 Cr9 Cr41 Cr47 Cr8 Cr16 Cr44 Cr27 Cr11 Cr15 Cr39 Cr
Tax %8.6%34.6%25.0%24.6%24.3%26.2%23.8%24.1%22.9%24.8%16.2%24.3%
Net profit2 Cr3 Cr7 Cr31 Cr36 Cr6 Cr12 Cr34 Cr21 Cr8 Cr12 Cr29 Cr
EPS (₹)₹1.42₹2.13₹5.31₹24.68₹28.39₹4.93₹9.87₹26.86₹16.85₹6.71₹9.77₹23.44

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales504 Cr611 Cr825 Cr702 Cr749 Cr1,178 Cr1,090 Cr826 Cr978 Cr1,095 CrSign in free for the trailing twelve months
Operating expenses (approx.)462 Cr488 Cr576 Cr573 Cr629 Cr948 Cr963 Cr803 Cr859 Cr985 CrSign in free for the trailing twelve months
EBITDA42 Cr123 Cr249 Cr129 Cr121 Cr230 Cr126 Cr23 Cr120 Cr110 CrSign in free for the trailing twelve months
OPM %8.3%20.1%30.2%18.4%16.1%19.6%11.6%2.8%12.2%10.0%Sign in free for the trailing twelve months
Other income10 Cr5 Cr6 Cr11 Cr9 Cr16 Cr13 Cr33 Cr30 Cr27 CrSign in free for the trailing twelve months
Interest10 Cr6 Cr2 Cr3 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 CrSign in free for the trailing twelve months
Depreciation14 Cr15 Cr18 Cr23 Cr27 Cr31 Cr31 Cr31 Cr34 Cr37 CrSign in free for the trailing twelve months
Profit before tax27 Cr107 Cr234 Cr115 Cr101 Cr213 Cr106 Cr23 Cr113 Cr98 CrSign in free for the trailing twelve months
Tax %25.6%30.9%34.5%16.4%29.5%24.5%24.4%24.9%24.5%22.6%Sign in free for the trailing twelve months
Net profit20 Cr74 Cr153 Cr96 Cr71 Cr161 Cr80 Cr17 Cr85 Cr76 CrSign in free for the trailing twelve months
EPS (₹)₹15.88₹58.78₹122.07₹76.43₹56.55₹128.24₹63.59₹5.31₹67.87₹60.19Sign in free for the trailing twelve months
Dividend payout %————0.0%8.8%35.3%83.4%8.1%22.8%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr
Reserves404 Cr526 Cr693 Cr695 Cr845 Cr1,143 Cr1,235 Cr1,421 Cr1,582 Cr1,697 Cr
Borrowings60 Cr8 Cr6 Cr21 Cr9 Cr5 Cr0.89 Cr—0.05 Cr0.09 Cr
Other liabilities149 Cr188 Cr210 Cr215 Cr251 Cr332 Cr250 Cr368 Cr332 Cr402 Cr
Total liabilities619 Cr728 Cr916 Cr937 Cr1,111 Cr1,487 Cr1,493 Cr1,796 Cr1,920 Cr2,105 Cr
Fixed assets (net)182 Cr202 Cr237 Cr332 Cr369 Cr407 Cr408 Cr408 Cr423 Cr438 Cr
CWIP8 Cr23 Cr12 Cr9 Cr17 Cr21 Cr19 Cr18 Cr8 Cr38 Cr
Investments211 Cr282 Cr395 Cr266 Cr366 Cr547 Cr625 Cr962 Cr1,100 Cr1,141 Cr
Loans & advances——4 Cr2 Cr2 Cr1 Cr1 Cr1 Cr1 Cr0.24 Cr
Inventories55 Cr56 Cr69 Cr78 Cr69 Cr165 Cr131 Cr106 Cr94 Cr129 Cr
Trade receivables120 Cr125 Cr158 Cr150 Cr173 Cr199 Cr157 Cr185 Cr216 Cr261 Cr
Cash & bank3 Cr4 Cr4 Cr21 Cr42 Cr30 Cr4 Cr8 Cr12 Cr13 Cr
Other assets39 Cr37 Cr37 Cr80 Cr73 Cr115 Cr147 Cr107 Cr65 Cr85 Cr
Total assets619 Cr728 Cr916 Cr937 Cr1,111 Cr1,487 Cr1,493 Cr1,796 Cr1,920 Cr2,105 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity31 Cr119 Cr135 Cr110 Cr91 Cr109 Cr125 Cr72 Cr62 Cr53 Cr
Cash from investing16 Cr-45 Cr-111 Cr-61 Cr-53 Cr-104 Cr-118 Cr-51 Cr-41 Cr-25 Cr
Cash from financing-48 Cr-73 Cr-24 Cr-31 Cr-17 Cr-17 Cr-35 Cr-17 Cr-16 Cr-27 Cr
Net cash flow-0.90 Cr0.79 Cr-0.45 Cr17 Cr21 Cr-12 Cr-27 Cr4 Cr4 Cr0.84 Cr
Free cash flow (OCF − Capex)-6 Cr67 Cr89 Cr44 Cr43 Cr35 Cr93 Cr40 Cr18 Cr-27 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %7.9%20.9%33.5%16.3%12.0%18.7%8.7%1.7%7.3%5.9%
ROE %4.9%13.9%21.9%13.7%8.3%14.0%6.4%1.2%5.4%4.4%
Debtor days87747078846252828087
Inventory days89757186709778806678
Days payable101118103116125106631399691
Cash conversion cycle75323848295367225074
OCF / EBITDA %74.1%97.1%54.3%85.1%75.3%47.3%99.1%n.m.51.7%48.2%
OCF / EBITDA % (3 years)——69.0%72.7%67.4%64.5%68.1%80.7%96.5%74.1%
Debt / equity0.150.010.00890.030.010.00460.0007—0.00000.0001
Current ratio1.501.872.911.992.212.453.792.703.192.49
Net debt / EBITDA1.35—0.010.0028-0.28-0.11-0.02-0.34-0.10-0.12